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AbstrACt
Objective To identify, characterise and explain common 
and specific features of the experience of treatment 
burden in relation to patients living with lung cancer or 
chronic obstructive pulmonary disease (COPD) and their 
informal caregivers.
Design Systematic review and interpretative synthesis of 
primary qualitative studies. Papers were analysed using 
constant comparison and directed qualitative content 
analysis.
Data sources CINAHL, EMBASE, MEDLINE, PsychINFO, 
Scopus and Web of Science searched from January 2006 
to December 2015.
Eligibility criteria for selecting studies Primary 
qualitative studies in English where participants were 
patients with lung cancer or COPD and/or their informal 
caregivers, aged >18 years that contain descriptions of 
experiences of interacting with health or social care in 
Europe, North America and Australia.
results We identified 127 articles with 1769 patients 
and 491 informal caregivers. Patients, informal caregivers 
and healthcare professionals (HCPs) acknowledged lung 
cancer’s existential threat. Managing treatment workload 
was a priority in this condition, characterised by a short 
illness trajectory. Treatment workload was generally 
well supported by an immediacy of access to healthcare 
systems and a clear treatment pathway. Conversely, 
patients, informal caregivers and HCPs typically did not 
recognise or understand COPD. Treatment workload was 
balanced with the demands of everyday life throughout 
a characteristically long illness trajectory. Consequently, 
treatment workload was complicated by difficulties of 
access to, and navigation of, healthcare systems, and 
a fragmented treatment pathway. In both conditions, 
patients’ capacity to manage workload was enhanced by 
the support of family and friends, peers and HCPs and 
diminished by illness/smoking-related stigma and social 
isolation.
Conclusion This interpretative synthesis has affirmed 
significant differences in treatment workload between lung 
cancer and COPD. It has demonstrated the importance of 
the capacity patients have to manage their workload in 
both conditions. This suggests a workload which exceeds 
capacity may be a primary driver of treatment burden.
PrOsPErO registration number CRD42016048191.
IntrODuCtIOn 
Burden of treatment (BoT) is not simply 
the unavoidable workload that illness inevi-
tably confers on patients and their informal 
caregivers but is a potentially modifiable work-
load which treatment for the illness may 
create.1This workload consists of affective, 
cognitive, informational, material, physical 
and relational tasks delegated to patients 
and/or their informal caregivers by health-
care professionals (HCPs).1 2 The literature 
on BoT discusses the concept of ‘capacity’ 
and defines this as the resources (which may 
be affective, cognitive, informational, mate-
rial, physical and relational) and limitations 
that affect patients’ capability to carry out 
the work of chronic illness.1 3 4 Capacity may 
be viewed at an individual (ie, the patient) 
or collective level (ie, the patients’ social 
strengths and limitations of this study
 ► To the best of our knowledge, this is the first system-
atic review and synthesis that compares treatment 
burden in malignant and non-malignant disease.
 ► The review synthesises patient and informal care-
giver experience of treatment burden across a wide 
range of healthcare settings and systems.
 ► The heterogeneity of studies included means unifor-
mities highlighted should facilitate the development 
of an explanatory model of burden of treatment.
 ► The data analysed, while ostensibly from primary 
sources, are seen through the multiplicity of theo-
retical lenses chosen by the studies’ authors and 
their varying epistemological and ontological stanc-
es and, indeed, the authors’ own which may be a 
limitation of the study.
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network).5 Capacity may be affected by a range of vari-
ables, from socioeconomic factors such as ethnicity 
and poverty, to the social skill necessary to engage and 
mobilise stakeholders.1–4 6–12 A workload that exceeds 
capacity might, in some cases, be a primary driver of BoT 
for patients.1 4 Neither workload nor capacity is static. 
They may fluctuate over time as illness progresses, func-
tional capacity declines and patients’ social networks 
change1 3 4 or, indeed, as the patient is able to accept, 
adapt and normalise their condition into their daily 
life.2 9 12 13 
The literature1 7 11 14 15 emphasises the importance of 
adequately equipping clinicians with tools to detect BoT 
and training in interventions that might ameliorate 
burden in order to provide ‘minimally disruptive medi-
cine’.15 This is an approach to healthcare that takes into 
account patient priorities, multimorbidity and seeks to 
reduce the BoT on the patient and informal caregiver.15
Chronic obstructive pulmonary disease (COPD) and 
lung cancer are the most common causes of respirato-
ry-related mortality in the UK, excluding pneumonia.16 
Tobacco smoking is the main risk factor for both diseases, 
linked to an estimated 86% of lung cancer and 90% of 
COPD cases in the UK.17 18 Thus, both may carry the 
stigma of a ‘self-inflicted’ disease.19 20
Tobacco is a legal drug, used commonly, and has been 
previously socially acceptable. More recently, recognition 
of the significant risks of tobacco smoking and public 
health strategies to ‘denormalise’ tobacco has contrib-
uted to a social transformation that actively stigmatises 
smokers.21
COPD generally has a protracted trajectory of increasing 
respiratory limitation, punctuated by recurrent episodes 
of worsening termed ‘exacerbations’. Globally, COPD 
is a major cause of chronic morbidity and mortality; 
prognosis is uncertain but many people die prema-
turely because of the disease or its complications (such 
as pneumonia).22 Conversely, lung cancer typically has a 
rapid trajectory involving steady progression with a clear 
terminal phase.23 The prognosis for lung cancer is poor; 
only 1 in 10 patients in the UK live for more than 5 years 
after diagnosis. Lung cancer treatments in England are 
predominantly hospital based: outpatient chemotherapy 
or systemic anticancer treatment or inpatient surgical 
treatment.24 In contrast, treatment for COPD generally 
involves self-management (management of treatment 
regimens by patients and informal caregivers in the 
home).25 BoT may, therefore, be experienced very differ-
ently by patients living with these two common respira-
tory conditions.
Aim of the review
We aimed to undertake a comprehensive search of the 
literature to identify, characterise and explain common 
and specific features in the experiences of treatment 
burden in relation to patients living with either lung 
cancer or COPD.
research question
What is BoT in lung cancer and COPD, and how is it 
experienced by patients and their informal caregivers?
MEthODs
Identifying relevant studies
This review forms part of a larger body of work which 
we are undertaking in order to identify, characterise 
and explain the intricate interpersonal and institutional 
processes that mediate patient and informal caregiver 
experiences of their interactions with healthcare. Thus, 
for this study we replicated and extended a previously 
developed search strategy which was built around three 
search concepts26 :
1. Index conditions (heart failure, chronic kidney disease 
and COPD).
2. Qualitative research methodology terms.
3. Patient/informal caregiver experience.
We initially ran the search based on the above index 
conditions. We subsequently ran a separate search 
with lung cancer as the index condition. The full 
search strategy as performed in MEDLINE is available 
in online supplementary appendix 1. The search was 
piloted in MEDLINE and then adapted for other elec-
tronic databases used (CINAHL, Embase, Scopus, Web 
of Science, PsycInfo). We looked at primary qualitative 
studies examining patients with COPD or lung cancer and 
their informal caregivers’ interactions with health and 
social care, rather than studies which explicitly examine 
treatment burden in COPD or lung cancer as there are 
so few. Searches were limited to countries with advanced 
healthcare systems comparable to the UK as the synthesis 
is intended to inform a future research project that will 
take place in the National Health Service in England. 
We limited our search to publications from the year 2006 
onwards. This is because, like Gallacher et al,7 we wanted 
to locate patient/informal caregiver experiences of BoT 
in current rather than historical health and social care 
practices. After retrieving and screening full-text articles, 
we decided not to use the mixed methods studies identi-
fied, as the majority of these studies screened suggested 
the qualitative components of the studies addressed a 
very specific research question, meaning that there was 
little data relevant to our research question. This is a 
potential limitation of the systematic review as there is 
a possibility that we have missed some pertinent studies. 
Table 1 details inclusion/exclusion criteria.
study selection
KAL, MM, AC and CRM individually screened batches 
of citations and abstracts to assess eligibility against the 
inclusion/exclusion criteria. A further reviewer (Jona-
than Harvey, see Acknowledgements) resolved eligibility 
disagreements at this stage. We obtained studies in full text 
where it was not immediately possible to determine eligi-
bility against inclusion/exclusion criteria. KAL, MM  and 
Jonathan Harvey independently double screened all 
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full-text COPD articles for eligibility; KAL screened all 
full-text lung cancer articles for eligibility with 10% of 
the full-text papers screened by CRM. A further reviewer 
(Katherine Hunt, see Acknowledgements) resolved eligi-
bility disputes at this stage.
Quality assessment
MM, AC, Jonathan Harvey and KAL undertook quality 
assessment of included papers using a modified version 
of the qualitative appraisal tool: RATS (Relevance, Appro-
priateness, Transparency, Soundness) guidelines27 (see 
online supplementary appendix 2). We took a conser-
vative approach to assessment, primarily undertaking 
it to ensure transparency of study design, aims and the 
sampled population. Thus, we excluded only five of the 
lung cancer studies that had not appeared to seek ethical 
permissions.
Data extraction and analysis
We extracted data from the findings/results, discussion 
and conclusion sections of each paper. Extracted data 
included verbatim quotes from patients and caregivers 
and authors’ interpretations.2 As the aim of the review 
was to identify and characterise patient and informal 
caregiver experience, we omitted results relating to HCPs 
in the analysis (n=12 studies included HCPs). CRM, 
AR, KAL, MM, AC and Jonathan Harvey developed a 
coding framework, underpinned by robust, empirically 
derived, middle-range theories: BoT theory (described 
above)1 and status passage theory.28 Middle-range theo-
ries are applicable to discrete conceptual ranges, sitting 
between frequently generated minor working hypoth-
eses and all-encompassing efforts to explain systemati-
cally the observed uniformities of society. They may be 
particularly helpful, therefore, in generalising learning 
in health services improvement so that interventions 
can be replicated in different contexts.29 Status passage 
theory describes people as constantly in passage between 
temporally limited and societally ascribed statuses (eg, 
from being unmarried to married). Status passages may 
(or may not) be desirable, inevitable, reversible, repeat-
able or voluntarily undertaken. They may vary in their 
importance to the person undergoing the passage. 
Passages may have to be legitimised by authorised agents. 
Status passage theory is a particularly useful tool when 
considering illness, which is an undesirable, involuntary 
and often irreversible passage, legitimised by HCPs as 
authorised agents.28
In keeping with the principles of directed qualitative 
content analysis which seeks to extend conceptually an 
existing theory, we identified key concepts of BoT and 
status passage theories as coding categories and deter-
mined operational definitions for these creating a coding 
framework.30 KAL, MM, AC and Jonathan Harvey then 
independently used the coding framework to code a 
selected group of data and compared results. Once inter-
coder reliability had been established, KAL downloaded 
full-text articles into the qualitative data analysis software 
Nvivo 11, used to organise and manage data. KAL read 
the full-text versions of identified papers to enable immer-
sion in the data to understand their scope and context31 
and coded data using the coding framework described 
above. KAL, supported by CRM and AR, analysed data 
using directed qualitative content analysis30 and constant 
comparison.32 We grouped related codes into sets for 
each condition and compared sets within and between 
conditions. We used Shippee et al’s4 proposition that 
a workload that exceeds capacity might be the primary 
driver of BoT and thus grouped coded data into sets of 
workload (the affective, cognitive, informational, material 
and relational tasks delegated to patients/caregivers) and 
capacity (the affective, cognitive, informational, mate-
rial and relational resources available to be mobilised by 
patients/caregivers). We then formulated simple explan-
atory propositions with which to characterise differences 
Table 1 Inclusion/exclusion criteria for systematic review
Inclusion criteria Exclusion criteria
Participants: aged >18 years, diagnosed with lung cancer or 
COPD, or their informal caregivers
Reports of treatment effectiveness, for example, RCTs; reports 
of healthcare provision which are not focused on patients’ or 
informal caregivers’ experiences; qualitative studies which 
focus only on professional experience, or report secondary 
analyses, or review or synthesise data; editorials, notes, letters 
and case reports; protocols of qualitative studies
Reports: results of primary qualitative studies of patients’ or 
informal caregivers’ experiences of interactions with health and 
social care services published in peer-reviewed journals
Insufficient data to answer research question
Settings: healthcare systems in Europe (excluding Turkey), 
North America and Australia
Date of publication: between 1 January 2006 and 31 
December 2015
Language: English
COPD, chronic obstructive pulmonary disease; RCT, randomised controlled trial.
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and similarities in treatment burden between condi-
tions. These propositions, with coded data as supporting 
evidence, were used to develop a taxonomy which iden-
tifies and characterises primary and secondary constructs 
of BoT in lung cancer and COPD (table 2).
reflexivity
As this was an interpretative synthesis, it was important to 
ensure that reflexivity was ongoing throughout the study. 
We did this first through discussions and reflections on 
the theoretical coding framework. Second, in discussions 
and reflections on extracted and coded data. Third, in 
reflections and discussions on the development of the 
simple explanatory propositions, supporting evidence for 
these and the development of the taxonomy.
Patient and public involvement
Our wider National Institute for Health Research (NIHR) 
funded programme of research on complexity, patient 
experience and organisational behaviour has been devel-
oped in engagement with three groups in which more 
than 40 patients and caregivers have played a substantial 
role. In this particular study, we worked closely with the 
late Mark Stafford-Watson (see Acknowledgements). He 
played a valuable role in the development of the research 
question. Emerging results from this systematic review 
have been discussed with members of a local Breathe 
Easy (British Lung Foundation patient support group), 
and these discussions have informed the development of 
empirical research following the review.
rEsults
Characteristics of studies
Figures 1 and 2 show each stage of the review process. We 
identified 127 articles: 85 COPD and 42 lung cancer. The 
papers included 1233 patients with COPD, 251 informal 
caregivers of patients with COPD; 536 patients with lung 
cancer and 240 informal caregivers of patients with lung 
cancer. The majority of the papers were set in the UK, 
USA, Canada and Sweden. Ninety-nine papers used qual-
itative interviews, 14 used interviews alongside either 
participant observation or focus groups. Eleven studies 
employed focus groups, two studies used case study and 
one study used serial dialogue. Further characteristics of 
studies are available in online supplementary appendix 
3 .
For ease of reference, we include a table with primary 
and secondary constructs (table 3).
Workload (primary construct)
Diagnosis (secondary construct)
For the majority of patients with COPD, the experience 
of receiving a diagnosis of COPD was not a memorable 
event33–46; ‘a story without a beginning’.43 Often, patients 
had never received a formal diagnosis or were not 
informed of their diagnosis for many years. One study 
described how its participants questioned why they were 
recruited, unaware that they had been diagnosed with 
COPD.42 Even when given a diagnosis, many patients 
often did not understand the term ‘COPD’: ‘… as I say, 
I wasn’t even sure, it had never been put to me, formally 
put to me that I’d got this obstructive pulmonary or what-
ever they call it’35 (p.706).
In contrast, patients with lung cancer almost univer-
sally described the moment of diagnosis as a ‘shock’,47–53 
an unexpected and undesirable ‘crisis’ which ‘flooded’ 
patients’ lives.28 Patients felt overwhelmed by the existen-
tial threat of cancer that took away their ability to plan for 
or even imagine a future.48 54 55
Illness identity (secondary construct)
Several studies demonstrated a lack of public under-
standing of COPD.33–35 37 39 42 43 45 56–59 Thus, patients and 
their informal caregivers often had not heard of COPD 
prior to diagnosis and therefore had no expectations of 
the disease and its likely trajectory: ‘When cancer was 
excluded all worries about the future or fear of death fell 
away’34 (p.558). Conversely, cancer has a recognisable 
public narrative, replacing tuberculosis as the disease 
the public most fears.60–63 In several of the studies, the 
patient’s experience reflected this narrative shift50 53 64: 
‘Patients acknowledged despair … and some hoped for an 
alternative diagnosis: ‘It doesn’t have to be lung cancer … 
it doesn’t have to be the worst’64 (p.1207).
Attitude towards treatment (secondary construct)
Consequently, treatment for the illness—often became 
the over-riding priority in life for patients with lung 
cancer,64–67 suspending the demands of everyday life: 
‘Life is immediately put on hold … so a normal everyday 
life didn’t concern me because everything revolved 
around treatment and only completion of the treat-
ment was important so everything else didn’t matter’66 
(p.5). Conversely, patients often saw COPD as a ‘way of 
life’43 not an illness. The management and treatment 
of ‘stable’ COPD symptoms was seen as something 
that had to be integrated into everyday life rather than 
being a priority.35 43 57 59 68–73 Many patients with COPD, 
even with advanced illness, did not regard themselves 
as unwell.43 59 70 71 73 Patients reported exacerbations of 
COPD as ‘proper’ illnesses but saw the often debilitating 
symptoms of ‘stable’ COPD as a normal part of life, some-
thing to be accepted and coped with.70
In the papers included, patients often described COPD 
as a ‘planning’ disease, balancing the work of everyday 
life with the material demands of managing their treat-
ment workload.42 72 74–79 This was complicated by the 
uncertainty of the illness trajectory making disease fluc-
tuations difficult to anticipate and, consequently, to 
manage.33 37 39 70 80–84 Less commonly, patients with lung 
cancer also described the importance of planning and 
managing their own treatment workload.47 66 67 85–87 More 
commonly, patients with lung cancer were overwhelmed 
by the debilitating pathophysiological side effects of 
their treatment such as breathlessness, fatigue, nausea 
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and vomiting and were unable to focus on anything 
apart from treatment completion.48 55 65–67 86 88–92 None-
theless, patients with lung cancer often experienced the 
practical demands of treatment—the treatment work-
load—as a relief, despite these potentially incapacitating 
pathophysiological side effects.51 53 86 93 Patients repeat-
edly used the metaphor of treatment as ‘hope’, a lifebelt 
in the existential flood caused by the diagnosis of lung 
cancer.49 51 64 86 87 91 94 95 Indeed, some patients reported 
a sense of ‘limbo’ once the practical workload of treat-
ment had finished.48 66 96–98 This ‘limbo’ was both exis-
tential66 98: ‘Now I have lived for something, to complete 
and survive the treatment and suddenly the priority of 
life is gone’66 (p.5) or structural, where patients felt in 
transition between healthcare institutions.48 96 97 Thus, 
paradoxically, patients with lung cancer could report a 
reluctance to stop treatment, despite its unpleasant patho-
physiological side effects: ‘I’ll keep taking chemo as long 
as you’ll give it to me’86 (p.105). Some patients with lung 
cancer also described continuing with treatment because 
they believed it was what their family wanted, rather than 
consulting their own preferences.67 87 99
Patients with COPD reported how elements of treatment 
that supported self-management (eg, educational sessions 
at pulmonary rehabilitation (PR)) provided a much 
needed sense of control over their condition.35 72 78 100–107 
Yet, it was evident how fragile this sense of control might 
be, easily undermined by structural disadvantages such 
as transitions between healthcare institutions and lack of 
communication from and between HCPs33 37 41 58 73 108 109:
I said, put them bloody tablets back [after one of 
usual medications stopped in hospital, followed by 
him feeling unwell]. Don’t take stuff off me without 
telling me. And I swore at him, [hospital doctor] I 
did, I was blazing. For giving me a dodgy thing again. 
But that’s what you’ve got to put up with you see.41 
(p.269)
This suggests unsupported and undermined self-man-
agement may be an exhausting and frightening, 
rather than empowering experience for the patient 
and their informal caregiver. Indeed, in the studies 
included, patients with COPD repeatedly describe the 
relief of respite from the demands of self-management 
that institutionally provided treatment (specifically 
Figure 1 PRISMA flowchart for COPD articles. CHF, 
congestive heart failure; CKD, chronic kidney disease; 
COPD, chronic obstructive pulmonary disease; PRISMA, 
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses; RATS, Relevance, Appropriateness, Transparency, 
Soundness.  
Figure 2 PRISMA flowchart for lung cancer 
articles. PRISMA, Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses; RATS, Relevance, 
Appropriateness, Transparency, Soundness. 
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hospitalisation, PR, day hospice and specialist outpatient 
care) brings57 58 84 104 109–119:
Sometimes you can think, when you’re too sick, that 
they (medical staff) can tell me what to do, so I don’t 
have to make all the decisions. I trust myself, but it 
would be nice if someone just took care of me like 
that.111 (p.1485)
However, particularly in the case of hospitalisation, insti-
tutionally provided treatment might also significantly add 
to the workload of patients with COPD. Patients reported 
a hospital stay as a chaotic, confusing and disruptive expe-
rience. They felt they were seen as ‘low priority’ by the 
healthcare provider and frequently moved from ward to 
ward.41 79 116 120 Thus, some patients might try to avoid 
hospitalisation.37 41 120
Identifying and accessing treatment options (secondary construct)
In the papers included, patients with lung cancer reported 
frequently having to make decisions about whether or 
not to have treatment, which they repeatedly phrased 
as a lack of choice: a choice between death or treat-
ment.67 91 93 97 121 While ostensibly involved in the treat-
ment decision-making process, some patients described 
having little real control over treatment options, believing 
they lacked the cognitive ability and specialist knowledge 
required to make informed treatment decisions.93 97 99 
Indeed, frequently patients reported choosing to cede 
the cognitive burden of decision-making over treatment 
options to a trusted HCP.86 93 97 99 121 122
For patients with COPD, identification of treatment 
options could, itself, be problematic.35 57 70 113 123 Patients 
described being repeatedly told that ‘nothing could be 
done for them’ by HCPs in both primary and secondary 
care.35 57 70 113 123 Thus, papers reported patients identi-
fying treatment options from other sources of infor-
mation such as the experience of peers or through 
their own research.56 57 68 108 113 Once treatment options 
were identified, patients could experience difficulty in 
accessing them.34 35 39 40 42 44–46 58 70 73 74 76 103 108 109 116 120 124–130
Access to and navigation of healthcare institutions/systems 
(secondary construct)
After diagnosis, patients with lung cancer frequently 
reported rapid access to healthcare institutions and 
specialist HCPs who recognised and understood lung 
cancer and were able to coordinate its treatment work-
load.49 67 85 121 131 132 Furthermore, patients with lung 
cancer appeared to follow a relatively structured treat-
ment pathway.49 53 66 67 85 121 131 132 In contrast, patients with 
COPD described encounters with gatekeeping gener-
alist HCPs who did not recognise or understand their 
disease44 45 58 78 109 112 113 116 124 126 129 and, consequently, 
significant delays in accessing specialist care. Patients 
with COPD reported the hard work of accessing health-
care, having to navigate between primary and secondary 
care, in a fragmented system, lacking a clear COPD treat-
ment pathway.34 37 42 44 45 58 73 74 76 103 108 109 116 120 126 127 129 
Furthermore, patients described being expected to act as 
custodians of their own medical history, having to update 
HCPs with changes to their treatment.109 133
Practical workload of treatment (secondary construct)
Once treatment options were identified and accessed, 
patients with both conditions reported experiencing a 
significant practical workload, with multiple appoint-
ments for treatment, most commonly in hospitals for 
cancer52 91 134 and occurring in a variety of settings for 
COPD.73 101 108 120 123 125 133 135 Patients with both condi-
tions described structural disadvantages such as the 
availability and cost of transportation and parking, 
physical restrictions in accessing healthcare (such as 
stairs), waiting for appointments and restricted time for 
appointments with HCPs that make their workload more 
onerous.34 39 42 52 58 73 91 101 108 109 120 123 125 126 129 134 135
Table 3 Primary/secondary constructs
Primary construct Secondary construct
Workload (the affective, cognitive, informational, material and 
relational tasks delegated to patients/caregivers)
Diagnosis/illness identity
Attitude towards treatment
Treatment options
Access to/navigation of healthcare system/institutions
Practical workload of treatment
Informational workload of treatment
Capacity
(the affective, cognitive, informational, material and relational 
resources available to be mobilised by patients/caregivers)
- Enhanced by diagnosis
Family and friends
Healthcare professionals
Peer support
Disease trajectory
Capacity
(the affective, cognitive, informational, material and relational 
resources available to be mobilised by patients/caregivers)
- Diminished by diagnosis
Stigma
Social isolation (self-imposed) 
Social isolation (involuntary) 
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Patients with COPD and their informal caregivers 
reported being delegated a wide range of material 
treatment tasks by HCPs to self-manage at home. These 
included the management of complex medication regi-
mens,33 35 42 72 74–76 80 109 129 130 136 the operation of technologies 
such as oxygen,42 45 58 59 73 79 83 106 108 109 126 127 136–143 nebu-
lisers33 68 80 126 127 140 and non-invasive ventilation.69 144 These 
also included self-management of the illness itself: avoiding 
exacerbation triggers, monitoring physical symptoms and 
help-seeking when appropriate.35 37 68 72–74 76 80 103 114 130 133 145 
In contrast, patients with lung cancer described receiving 
highly specialised, predominantly hospital-based ther-
apies with little delegation of material treatment 
tasks.48 50 52 53 65–67 86 89 91 93 97–99 121 131 146 The exception was 
a study interviewing patients receiving oral targeted ther-
apies who described the rigorous process they underwent 
when securing and taking medication.87 This paper high-
lighted the priority patients with lung cancer gave to their 
treatment because of the recognition of lung cancer’s 
immediate threat to life as they rigidly adhered to their 
delegated task.87
Informational workload of treatment (secondary construct)
Patients with both conditions described being required to 
comprehend a large amount of information about their 
treatment.35 37 51 56 64 66–68 73 83 85 88 89 94 96 97 99 103 108 121 130 132 
133 136 141 147–150 Commonly, patients with lung cancer felt 
that high-quality information about their treatment was 
available to them when they required it.64 67 85 93 97–99 121 
132 147 148 151 Nonetheless, the ‘shock’ of diagnosis meant 
some patients struggled to retain or process information 
about treatment and therefore felt that further infor-
mation was required once they began to assimilate their 
diagnosis.53
Some patients with lung cancer wanted to be fully 
informed about their condition and treatment by their 
HCP, including prognosis, however bleak this was.67 85 98 
121 132 147 148 In contrast, other patients found being fully 
informed overwhelming and frightening, particularly 
when given comprehensive written materials.53 97 147 They 
wanted limited information from HCPs, appearing to 
use this as a coping strategy to maintain hope for as long 
as possible,48 51 64 66 97 99 121 122 152 153 preferring not to be 
‘frightened with too much … knowledge’97 (p.969).
In a minority of cases, patients with lung cancer 
described information as not forthcoming when they 
wanted it and, as a consequence, felt ill-informed.94 99 122 147 
This was more frequently the case in patients with COPD. 
Patients often felt poorly informed about their condition 
and treatment at diagnosis and this continued throughout 
their disease trajectory.33–46 74 76 78 81 108 123 127 130 133 137 154 
This could be as fundamental as being given an inhaler 
without instructions on how to use it.42 45
Information could become a source of anxiety in both 
COPD and lung cancer when it was inconsistent or contra-
dictory.36 44 56 79 89 96–98 109 110 122 Patients with lung cancer 
found the side effects of treatment about which they had 
not been informed, significantly more distressing than 
those symptoms about which they had been warned and 
therefore anticipated.88 89
Capacity (primary construct)
We found, in both conditions, capacity could be enhanced 
and/or, paradoxically, diminished following diagnosis.
Capacity enhanced following diagnosis
Family and friends (secondary construct)
Patients with lung cancer and COPD repeatedly described 
family and friends as the main source of support for their 
treatment workload.37 49 55 58 66 67 73 74 76 79 80 87 108 125 130 132 147 
Informal caregivers, like patients with lung cancer, prior-
itised the demands of treatment workload over the 
demands of everyday life and thus put their own life on 
hold:
Participants and carers described their … life as 
inextricably tied to and affected by treatment pat-
terns, appointments, complications and side effects. 
Additionally, the impact of various test results cre-
ated a ‘scan by scan’, ‘treatment cycle by cycle’ or 
‘suspended’ approach to life, which had an impact 
not only for the patient but also carers and family.67 
(p.24)
There could be an explicit recognition that this was 
possible owing to the short disease trajectory in lung 
cancer.54
Informal caregivers’ participation in the treatment 
workload, while practically onerous, was often seen as an 
affirmation of the strength of their relationship with the 
patient.55 66 132 151 This was echoed in many of the COPD 
studies.36 73 79 80 130 Indeed, there was a suggestion from 
some informal caregivers that the demands of the caring 
role deepened and enhanced their relationship with the 
patient over the protracted COPD disease trajectory.58 74 
Yet, still more studies demonstrate that informal care-
givers felt ‘compelled’ to take on a caring role rather 
than this being a conscious choice. Their identity imper-
ceptibly and inexorably shifted from family member to 
caregiver.36 37 74 76 80 130 133 136The length of the disease 
trajectory in COPD meant that the informal caregiver, 
like the patient, had to balance the demands of treat-
ment workload with the demands of everyday life.36 74 
76 130 133 136 The studies included repeatedly show that 
informal caregivers might find this practically limiting 
and affectively and cognitively demanding.36 37 69 74 76 80 83 
130 133 136 137 145
Interestingly, despite the evidence of significant work-
load encountered by informal caregivers in COPD, it 
was patients with lung cancer who consistently described 
their fear of being a ‘burden’ on their caregivers.49 52 54 
85 86 91 95 96 99 132 147 This was less common in the COPD 
studies,42 75 101 127 perhaps because the gradual develop-
ment of the caring role over the long disease trajectory 
meant that the tasks the caregiver took on were not always 
obvious to the patient.
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HCPs (secondary construct)
Patients with lung cancer frequently reported the impor-
tance of support from empathetic, trusted specialist HCPs 
in whom they had faith.49 53 66 85–87 93 97 121 122 131 132 Patients 
with COPD also described positive experiences of interac-
tions with HCPs,125 129 particularly those with a specialist 
interest in COPD57 78 80 103 106 109 120 127 or those with whom 
they had relational continuity.80 109 125 129 Patients with 
COPD described lack of relational continuity with HCPs 
as making access to, and navigation of, the healthcare 
system more challenging.81 109 111 129 In a small minority 
of lung cancer cases, patients had lost confidence in their 
HCPs.85 122 This loss of confidence in HCPs appeared 
more common in COPD.35 38 41 44 45 73–76 109 113 123 126
Peer support (secondary construct)
Patients with COPD appeared to benefit hugely from 
peer support,40 68 82 108 which they generally accessed 
through PR.56 57 100–105 107 115 135 155 Peer support had 
both psychosocial benefits as patients felt less isolated56 
100–102 104 105 107 115 135 and practical benefits as a means 
of information sharing about treatment options.56 57 In 
contrast, there appeared to be little formal peer support 
accessed by patients with lung cancer. Interactions with 
other patients tended to be impromptu and often transi-
tory91 97 156 perhaps because of the typically short disease 
trajectory of lung cancer.
Disease trajectory (secondary construct)
Patients with COPD described a process of getting to 
know their bodies and symptoms over their long disease 
trajectory and, through a process of trial and error, being 
able to adapt and normalise treatments into their daily 
life.35 37 42 68 73 103 114 150 Patients attending PR reported the 
importance of support to self-manage, and education 
and information about their condition from specialist 
HCPs.78 101–106 115 In contrast, patients with lung cancer 
described feeling ill-equipped to self-manage symptoms 
such as breathlessness at home, particularly in the earlier 
stages of treatment.92 This may be because the short 
disease trajectory of lung cancer does not allow patients 
to develop adequate self-management techniques and/or 
because patients/informal caregivers do not see self-man-
agement as appropriate or possible.
Capacity diminished following diagnosis
Stigma (secondary construct)
Stigma occurs when society labels someone ‘tainted’ or 
‘spoiled’ on the basis of an attribute that signals their 
difference to a societally perceived norm.157 Scam-
bler62 usefully distinguishes between ‘enacted’ and ‘felt’ 
stigma.62 ‘Enacted’ stigma is actual discrimination by 
society against people with stigmatising conditions. ‘Felt’ 
stigma is internalised stigma by people with stigmatising 
conditions, manifesting itself as shame, guilt or blame or 
as fear of ‘enacted’ stigma.
In the papers included, patients with lung cancer and 
COPD frequently reported being considered culpable 
for their illness through smoking and consequently stig-
matised by society.38 40 75 113 126 151 158 Patients with both 
conditions clearly internalised this stigma, repeatedly 
describing their diseases as ‘self-inflicted’.33 35 44 75 77 79 85 101 
158–160 They experienced ‘felt’ stigma of self-blame, guilt 
and shame.38 40 44 49 75 79 85 101 145 152 158 159 Some patients with 
COPD described how this internalised stigma led them to 
believe they do not deserve treatment40 101: ‘I refused to go 
to the doctor. I thought it [COPD] was self-inflicted. If it’s 
self-inflicted, why bother anyone?’101 (p.314). Conversely, 
in the papers included, patients with lung cancer did not 
describe themselves as undeserving of treatment. Only 
one patient in one lung cancer study reported having to 
‘endure’ the unpleasant side effects of treatment because 
of his smoking history.147
Both COPD and lung cancer are not immediately 
visible to others. Patients reported how fear of ‘enacted’ 
stigma led them to conceal their illness identity.38 40 49 152 
Thus, patients with both conditions attempted to impose 
a ‘closed awareness context’,28 concealing their illness 
from all but a select few. Patients with both conditions 
also experienced the fear of ‘enacted’ stigma when 
‘marked’ as unwell by their treatment.42 87 91 137 143 Hair 
loss caused by the side effects of lung cancer treatment is 
a clear signal of illness as is the ambulatory oxygen carried 
by some patients with COPD. In both conditions, there-
fore, the visible side effects of treatment or technologies 
may disrupt the ‘closed awareness context’28patients have 
carefully maintained around their illness identity, leading 
to patients avoiding social situations and, consequently, 
social isolation42 126
Patients with COPD often described feeling stigma-
tised by their HCPs.39 40 44 71 74 75 118 126–128 Patients with 
COPD and their informal caregivers felt that HCPs 
believed that patients who had smoked were not enti-
tled to treatment or gave substandard treatment to (ex)
smokers39 75 126 128:
Well, the care from Father’s doctors was extremely 
basic and, I felt, on the most part extremely uncar-
ing …. The doctors really had an attitude of ‘You 
were a smoker, you’re dying of lung disease, and what 
do you want us to do about it36 (p.161).
Consequently, patients were reluctant to access treat-
ment for fear of such enacted stigma.38 40 Several papers 
reported the difficulties of accessing treatment for 
patients who had smoked.36 75 126 128 One study described 
an extreme example of HCP stigma where the authors 
argue that patients receiving non-invasive ventilation, an 
unpleasant treatment for exacerbations of COPD, expe-
rienced this as a ‘punishment’ for their ‘self-inflicted’ 
disease.118
In contrast, in the studies included, patients with lung 
cancer did not describe encountering stigmatising atti-
tudes from HCPs. Only one patient in one study was 
concerned that their care would be affected because of 
the links the disease had to smoking.158
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Social isolation (secondary construct)
Self-imposed social isolation
Frequently, patients with lung cancer and COPD experi-
enced social isolation because of their illness.36 37 42 53 66 
74 76–80 82 96 101 102 111 114 126 127 133 136 139 143 145 156 161 162 This 
might be self-imposed because of embarrassment about 
visible symptoms (such as breathlessness and cough), 
medications (such as inhalers) or health technologies 
(such as oxygen) that mark patients as ill and therefore 
expose them to the threat of enacted stigma.42 77 87 90 91 
137 142 143 Additionally, in COPD, self-imposed isolation 
was also used as a self-management technique to avoid 
exacerbation triggers (such as the risk of infection from 
crowds).76 111
Involuntary social isolation
Social isolation might likewise be involuntary in both 
lung cancer and COPD as friends withdrew and social 
networks contracted.50 53 82 101 136 143 156 Patients reported 
feeling ‘contagious’ (p.734)50, (p.145).136. In both condi-
tions, social isolation was also a result of common psycho-
logical comorbidities such as depression, low mood and 
anxiety following diagnosis leading to avoidance of social 
situations.53 78 79 82 101 102 156
Patients with COPD reported that the practical and logis-
tical challenges of the treatment workload itself (eg, the 
weight of portable oxygen cylinders, the fear of running 
out of oxygen while waiting for appointments, having 
complex technologies such as non-invasive ventilation at 
home) further added to involuntary social isolation.38 42 58 
59 69 73 79 108 111 126 137 139–141 143 In COPD, involuntary social 
isolation also appeared to worsen with disease progres-
sion and the consequent relentless deterioration of phys-
ical function.37 74 80 82 127 139 161 162 This clearly extended 
beyond the patient to affect the informal caregiver as 
their responsibilities increased with the pathophysiolog-
ical decline of the patient.36 37 74 76 80 133 136 In the papers 
included, there were fewer accounts of this from patients 
with lung cancer, perhaps because of the typically short 
disease trajectory.96
DIsCussIOn
Illness as agent; patient as agent
The over-riding discourse evident throughout the lung 
cancer studies is that of ‘illness as agent’. Patients with lung 
cancer, informal caregivers and HCPs immediately recog-
nise lung cancer as an existential threat. In order to stave 
off death, the significant demands of treatment workload 
become the over-riding life priority in what is typically a 
short illness trajectory. Patients with lung cancer have to 
undergo a gruelling treatment workload in secondary 
care, with potentially debilitating pathophysiological 
side effects but limited delegated tasks from HCPs. This 
workload is generally well supported by an immediacy of 
access to healthcare institutions and specialist HCPs and a 
typically clear and structured treatment pathway. Patients 
with lung cancer often regard the practicalities of the 
treatment workload as a relief from the cognitive burden 
the existential threat of their illness identity has imposed. 
Patients and informal caregivers use the simile of ‘treat-
ment as hope’ and may be reluctant to stop treatment, 
despite potentially devastating side effects.
Conversely, the recurrent theme throughout the COPD 
studies is that of ‘patient as agent’. Patients do not recog-
nise or understand their illness and therefore do not 
consider it a terminal disease. Consequently, the demands 
of treatment workload are balanced with the domestic, 
professional and sentimental demands of the workload of 
everyday life throughout the typically long illness trajec-
tory. Patients with COPD are delegated a wide range of 
highly complex treatment tasks by HCPs to self-manage 
at home. This workload may be made more onerous by 
difficulties of access to, and navigation of, primary and 
secondary healthcare systems, generalist professional 
gatekeepers who lack understanding of COPD and a frag-
mented treatment pathway that does not meet the needs 
of home-based self-management. Synthesis of patient and 
informal caregiver accounts demonstrates that poorly 
supported self-management is hard, unrelenting work 
for patients with COPD and their informal caregivers. 
Patients and their informal caregivers can build up strat-
egies over time to self-manage their condition more 
effectively, particularly when supported by healthcare 
provision such as PR. Nonetheless, pathophysiological 
deterioration and increasingly complex management and 
treatment regimens mean that the demands of the treat-
ment workload over the long disease trajectory accumu-
late. Thus, institutionalised care that temporarily relieves 
patients and informal caregivers of the practical, affective 
and cognitive workload of self-management may be seen 
as a welcome respite from self-management. Yet patients 
with COPD often lack access to such specialist, institution-
alised care, especially at the end of life.112 163
Social skill, capital and structural resilience
Patients with lung cancer and COPD are typically able to 
draw on the support of family and friends which enhances 
their social skill (the extent to which they are able to secure 
the cooperation and coordination of others) and social 
capital (their ability to access informational and material 
resources), bolstering their structural resilience (their 
potential to absorb adversity).1 Like patients themselves, 
informal caregivers of patients with lung cancer recog-
nise cancer’s existential threat and prioritise supporting 
the treatment workload over the demands of everyday 
life. This support can be a cathartic and life-enhancing 
process for patients and informal caregivers alike. While 
this can also apply in COPD, informal caregivers often 
lack choice in taking on the caregiving role, describing 
an inexorable process of accumulating responsibility over 
the long disease trajectory as patients’ functional perfor-
mance deteriorates. In lung cancer, informal caregivers 
may also lack choice in taking on the caregiving role but 
the disease trajectory (and thus the caring trajectory) is 
shorter.
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The ‘weaker ties’164 of peer support are extremely 
important in enhancing the social skill and capital of 
patients with COPD and bolstering structural resilience. 
In lung cancer, because of its high mortality and short 
disease trajectory, patients are less likely to need peer 
support, or indeed, be able to access it as their peers die 
around them.
Illness-related and especially smoking-related ‘felt’ and 
‘enacted’ stigma degrade the social skill and capital of 
patients with both conditions. The invisibility of both condi-
tions, unless ‘marked’ by treatment means that patients may 
attempt to conceal their condition, leading to social isola-
tion. Social isolation is increased by the psychosocial impact 
of diagnosis and pathophysiological deterioration caused by 
both illness and the side effects of treatments. Stigma and 
social isolation and the consequent loss of opportunities to 
use social skill and access capital reduces the structural resil-
ience of patients with both conditions.
strengths and limitations
This systematic review and qualitative synthesis differs 
from previous reviews on BoT. BoT has been examined 
generally across many conditions,2 12 with capacity consid-
ered specifically.3 Other systematic reviews are condition 
specific: heart failure8 10 and stroke.9 Yet more consider 
treatment burden in multiple chronic conditions: 
diabetes, chronic kidney disease and heart failure6 and 
chronic kidney disease, heart failure and COPD.165 This 
review, like May et al,165 considers patient and caregiver 
interactions with healthcare services in order to charac-
terise treatment burden but identifies primary qualitative 
papers rather than systematic reviews and meta-syntheses.
To the best of our knowledge, this review is the first to 
explicitly compare BoT in malignant and non-malignant 
disease. As such, it offers a novel review which synthesises 
patient and informal caregiver perspectives on BoT in 
malignant and non-malignant disease across a range of 
healthcare systems and settings. It identifies and char-
acterises BoT in lung cancer and COPD through the 
development of a taxonomy (table 2). This has important 
implications both for researchers seeking to understand 
BoT and for clinicians, as they seek to ameliorate the 
impact of treatment on respiratory patients and their 
informal caregivers. We have made recommendations for 
clinical practice which can be found in box 1.
The heterogeneity of the papers included is both a 
strength and limitation of this synthesis. The heteroge-
neity of papers means uniformities identified through the 
taxonomy should facilitate the development of an explan-
atory model of BoT.166 However, the taxonomy has been 
developed from descriptions of patient experience taken out 
of context. It describes the generalities of patient experience 
across multiple healthcare systems and settings, rather than 
considering factors such as socioeconomic status and the 
attributes of healthcare systems that have been shown to be 
important in the consideration of BoT.1 Furthermore, qual-
itative research is, necessarily, interpretative and therefore 
the data analysed, while ostensibly from primary sources, are 
seen through the multiplicity of theoretical lenses chosen by 
the studies’ authors and their varying epistemological and 
ontological stances. Finally, this paper itself uses an inter-
pretative framework for synthesis and therefore results are 
refracted through the authors’ own lenses.
We limited our search to publications between January 
2006 and December 2015 as we intended to identify BoT 
in COPD and lung cancer with the aim of informing 
current healthcare practice and policy. In their discussion 
of the methodological challenges of reviewing patient 
experience of treatment burden in stroke, Gallacher et 
al7 highlight how the management of chronic disease 
has changed dramatically in recent years. We believed it 
was important, therefore, that pertinent (and thus more 
recent) literature was identified and reviewed to ensure 
that patient experience of treatment burden was based 
on current rather than historical healthcare practices. 
The systematic review took some time to undertake and 
write up, hence publications after December 2015 are not 
included which is a limitation.
We excluded studies that were not in peer-reviewed 
journals (ie, grey literature) and studies that are not in 
the English language because of resource constraints 
which could be regarded as a limitation.
What is not in the literature?
The studies identified focus almost exclusively on the 
index conditions of lung cancer and COPD. Studies focus 
on lung cancer or COPD, whereas many patients may 
have both lung cancer and COPD.167They do not discuss 
the issue of multimorbidity which is common in both 
conditions168 169 and is likely to have a significant impact 
on BoT.4
COnClusIOns
This interpretative synthesis of qualitative literature on 
patient/informal caregiver interactions with healthcare 
in lung cancer and COPD demonstrates that the work-
load of treatment may be very different in each condi-
tion. The sociocultural status of cancer as one of the most 
feared of all diseases60 61 means that ‘illness is agent’. 
Thus, lung cancer patients are required to subordinate 
the demands of everyday life to the demands of the treat-
ment workload. Patients have little choice but to follow a 
box 1 recommendations for clinical practice
 ► Patients living with respiratory disease and their informal caregiv-
ers may experience treatment as hard work. Equally, patients and 
caregivers may see treatment as ‘hope’ and therefore be reluctant 
to stop.
 ► Patients’ capacity to undertake the treatment workload may be 
enhanced and/or diminished by diagnosis. Consideration should 
be given to the volume of treatment workload delegated to the pa-
tient/informal caregiver and their capacity undertake this workload. 
Clinicians could use the taxonomy (table 2) to aid and support con-
sideration and discussion of workload and capacity.
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structured treatment pathway, in healthcare systems that 
generally meet the needs of their typically short diseases 
trajectory. Conversely, in COPD, patients are expected to 
exert agency over their own condition, ‘empowered’ to 
self-manage, integrating the demands of the treatment 
workload into their everyday life. Patients have to identify 
their own treatment pathway, navigating between institu-
tions, in healthcare systems that are not set up to meet 
the needs of their uncertain and often lengthy disease 
trajectory. The differences in the treatment workload of 
lung cancer and COPD identified by this synthesis reso-
nate with other qualitative studies comparing cancer with 
other chronic conditions (predominantly heart failure 
but also COPD and motor neuron disease).61 170 171
Despite the differences of the treatment workload 
between conditions, this interpretative synthesis has 
demonstrated the importance of the personal and collec-
tive capacity available to patients and their informal care-
givers in both conditions, suggesting that a workload 
which exceeds capacity is likely to be a primary driver of 
treatment burden.
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